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In complex retroviruses including simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1), the major
structural proteins are encoded by the gag gene and translated as a precursor polyprotein, Pr55Gag. An internal ribosome entry site (IRES) within
the coding region of HIV-1 and HIV type 2 (HIV-2) gag RNA mediates expression of N-terminally truncated isoforms of the precursor
polyprotein. In this study, we identify an N-terminally truncated SIV Pr55Gag isoform expressed from the SIV gag gene SIV p43. We demonstrate
that translation of p43 occurs independently of Pr55Gag translation and initiates at an in-frame AUG within the gag transcript. We test several
mechanisms that could mediate translation of p43 and report that translation of SIV p43 is driven by an IRES located entirely within the coding
region of gag mRNA. Additionally, we present data that suggest SIV p43 affects viral replication in cell culture.
© 2006 Elsevier Inc. All rights reserved.Keywords: SIV; Gag; Translation initiation; IRESIntroduction
The gag gene of simian immunodeficiency virus (SIV) and
human immunodeficiency virus type 1 (HIV-1) encodes the
major structural proteins, which are expressed as a precursor
polyprotein, Pr55Gag (Ratner et al., 1985). As a nascent virion
buds from a producer cell, and shortly thereafter, Pr55Gag is
cleaved by a virus-encoded protease (PR) into the four major
structural proteins: matrix (MA), capsid (CA), nucleocapsid
(NC) and p6 (Henderson et al., 1990; Mervis et al., 1988; Rue et
al., 2005). Although several accessory proteins are required for
assembly of infectious viral particles, Pr55Gag is sufficient to
direct formation of non-infectious virus-like particles (VLPs)
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doi:10.1016/j.virol.2006.01.034virions (Delchambre et al., 1989; Gheysen et al., 1989;
Karacostas et al., 1989).
In addition to the structural proteins generated from PR-
mediated cleavage of Pr55Gag, both HIV-1 and HIV type 2
(HIV-2) have been shown to express N-terminally truncated
Pr55Gag (Pr57Gag in HIV-2) isoforms, HIV-1 p40, HIV-2 p50
and HIV-2 p44 (Buck et al., 2001; Herbreteau et al., 2005;
Mervis et al., 1988). Though HIV-1 p40 is expressed at very low
levels compared to Pr55Gag, replication of an HIV-1 p40(−)
virus is severely impaired, indicating that the protein plays an
important role in the HIV lifecycle (Buck et al., 2001).
Translation of HIV-1 p40, HIV-2 p50 and HIV-2 p44 is
mediated by internal ribosome entry sites (IRESs) (Buck et al.,
2001; Herbreteau et al., 2005), which are structural RNA
elements that directly recruit translation machinery and thus
bypass the cap-dependent, scanning mechanism characteristic
of canonical translation initiation [for reviews see (Hellen and
Sarnow, 2001; Vagner et al., 2001)]. IRESs, initially discovered
in studies of picornaviruses, have been identified in the 5′
leaders of several retroviruses including HIV-1 and SIV (Attal et
al., 1996; Berlioz and Darlix, 1995; Berlioz et al., 1995; Brasey
et al., 2003; Buck et al., 2001; Deffaud and Darlix, 2000;
Fig. 1. Expression of p43 from proviral clones of SIVmac239. (A) Virus (V) or
cell (C) lysates prepared from COS-1 cells that were transfected with the
control vector pEGFP-N1 (Clontech), SIVmac239 proviral DNA, or D(25)
APRSIVmac239 proviral DNA and labeled with [
35S]Met/Cys were immuno-
precipitated with IgG-purified SIV CA polyclonal antiserum. Immunopreci-
pitates were resolved by SDS-PAGE and visualized by phosphorimager
analysis. (B) Lysates prepared from COS-1 cells that were transfected with
GFP or the gag-alone constructs SIV Pr55GagpCI, FSMA, or M(1)IMA were
labeled and immunoprecipitated as in panel A.
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1995).
Whereas the majority of IRESs are found in 5′ untranslated
regions (UTRs), the IRES that drives expression of HIV-1 p40
(herein referred to as the HIV-1 gag IRES) is noteworthy
because it is located entirely within the coding region of gag
RNA. Another surprising feature of the HIV-1 gag IRES is that,
in addition to driving expression of p40, it appears to promote
translation of Pr55Gag from the upstream gag start codon (Buck
et al., 2001). The recently characterized HIV-2 IRES shares
similar properties (Herbreteau et al., 2005). Thus, in conjunc-
tion with the HIV-1 leader IRES, expression of HIV-1 Pr55Gag
may be mediated by two distinct IRESs: one in the traditional
upstream position, one in an unusual downstream position.
Furthermore, because HIV mRNAs possess the 5′ m7-guano-
sine (m7G) cap structure required for canonical, cap-dependent
translation, expression of HIV-1 Pr55Gag can potentially
be regulated by multiple mechanisms, which may be exploited
by the virus at particular times in the viral and/or cell life
cycle.
In this study, we identify an N-terminally truncated SIV
Pr55Gag isoform, SIV p43, which is expressed from the SIV gag
transcript independently of Pr55Gag. Strong similarities between
SIV p43 and HIV-1 p40, including approximate molecular
weight and relative abundance of each compared to their
respective Pr55Gag levels, led us to hypothesize that translation
of SIV p43, like that of HIV-1 p40, is mediated by an IRES. We
have performed rigorous tests to eliminate other potential
mechanisms including leaky ribosome scanning and translation
from alternate gag transcripts. The results of these studies
clearly demonstrate that SIV p43 is translated from full-length
gag RNA in a cap-independent manner and is stimulated when
cap-dependent translation is inhibited, consistent with IRES-
mediated translation. Like the HIV-1 and HIV-2 gag IRESs, the
SIV gag IRES is located entirely within the coding region of
gag RNA. However, unlike the HIV-1 and HIV-2 gag IRESs,
the IRES identified in this report does not appear to drive
efficient translation of Pr55Gag. Despite this potential difference
in the activity of the HIV and SIV gag IRESs, their similarities
in location within the transcript and ability to mediate
translation of Pr55Gag isoforms provide compelling evidence
that IRESs play an important role in retrovirus biology.
Results
SIV p43 is a novel Pr55Gag isoform
In studies of Pr55Gag maturation, our laboratory has
consistently observed expression of a protein, herein referred
to as SIV p43 (for reasons described below) in [35S]-labeled
lysates of COS-1 cells transfected with SIVmac239 proviral
DNA (Fig. 1A). SIV p43 is recognized specifically by antibody
raised against the SIV CA protein but appeared to be a different
size than any predicted Pr55Gag cleavage intermediate (Rue et
al., 2005). SIV p43 is also observed in lysates of cells
transfected with a viral protease (PR)-inactive mutant D(25)
APR SIVmac239, demonstrating that p43 is not the product ofPR-mediated cleavage of the precursor polyprotein, Pr55Gag
(Fig. 1A). In fact, SIV p43 is expressed from a gag-alone
expression vector that lacks PR entirely, SIV Pr55GagpCI (Fig.
1B). We also detected p43 in immunoblots of cell lysates from
293T cells transfected with SIVmac239, D(25)APR SIVmac239,
and SIV Pr55GagpCI, indicating that SIV p43 expression is not
cell-line-specific (data not shown). Furthermore, we detected
SIV p43 in lysates of primary adult rhesus macaque macro-
phages infected with a macrophage-tropic SIV clone, SIV 17E-
Fr (Flaherty et al., 1997), indicating that p43 is also produced in
this primary target cell of HIV/SIV infection (data not shown).
SIV p43 is also detected in lysates of virus particles isolated
from the supernatants of cells transfected with SIVmac239 and
D(25)APRSIVmac239, indicating that p43 is incorporated into
SIV virions (Fig. 1A). The relative amount of SIV p43 detected
in wild-type SIVmac239 virions is much lower than in protease
mutant D(25)APR SIVmac239 virions (in fact, in SIVmac239
virions, p43 is only clearly detectable in very dark exposures),
suggesting that SIV p43 is a substrate for PR.
To address the possibility that p43 arises from cleavage of
Pr55Gag by a cellular protease or simply results from Pr55Gag
degradation, several mutations were introduced into the gag-
alone expression vector SIV Pr55GagpCI, and the precursor/
product relationship between Pr55Gag and p43 was examined. If
a precursor/product relationship exists between Pr55Gag and
p43, mutations that eliminate Pr55Gag should abolish expression
of SIV p43 as well. Therefore, we constructed two mutants
that completely abolish expression of Pr55Gag: FSMA, which
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Pr55Gag start codon, resulting in the introduction of 40
premature stop codons in the gag transcript, and M(1)IMA,
which mutates the initiator AUG of Pr55Gag to AUC. In cells
transfected with either FSMA or M(1)IMA SIV, p43 is expressed
to a greater extent than in wild-type SIV Pr55GagpCI, clearly
demonstrating that SIV p43 is translated independently of
Pr55Gag (Fig. 1B). Thus, we conclude that SIV p43 is a distinct
viral protein expressed from SIV gag independently from
Pr55Gag.
Translation of SIV p43 initiates at AUG118
Because SIV p43 is recognized by antibody to SIV CA, we
postulated that translation of SIV p43 initiates at an in-frame
start codon within the coding region of the gag transcript. We
first attempted to identify the N-terminal amino acid sequence
of SIV p43 by Edman sequencing; unfortunately, the reaction
was blocked due to an undetermined N-terminal modification
(data not shown). Therefore, we undertook a mutagenesis
strategy to identify the start codon for SIV p43. The coding
region of SIVmac239 gag contains three in-frame AUG codons
that could potentially be start sites for translation of p43 based
on the approximate size of the protein, taking into account that
the N-terminal modification could alter gel mobility. These
codons were mutated individually to AUC within the context of
SIV Pr55GagpCI, resulting in the mutants M(30)IMA, M(118)
IMA, and M(189)IMA. While the M(30)IMA and M(189)IMA
substitutions had no effect on SIV p43 levels, SIV p43
expression was completely abolished by the M(118)IMA
substitution, providing strong evidence that translation of SIV
p43 initiates at AUG118 (Fig. 2A). The absence of p43 in M
(118)IMA was further confirmed by a much darker exposure
(Fig. 2A, bottom). These experiments show that SIV p43 is anFig. 2. Identification of the start codon for SIV p43. (A) Lysates prepared from
COS-1 cells that were transfected with pEGFP-N1 or the gag-alone constructs
M(30)IMA, M(118)IMA, or M(189)IMA were labeled and immunoprecipitated as
in Fig. 1A. The bottom panel is a darker exposure of the gel shown in the top
panel. (B) Schematic representations of Pr55Gag and p43.N-terminally truncated Pr55Gag isoform, comprised of the C-
terminal 17 amino acids of MA (assuming that the initiator Met
is cleaved), followed by CA, p2, NC, p1, and p6 in their entirety,
with a predicted molecular mass of approximately 43 kDa. A
schematic diagram illustrating SIV p43 relative to the
constituent domains of Pr55Gag is presented in Fig. 2B.
SIV p43 is not translated from alternative gag RNAs
A hallmark of HIV/SIV biology is the production of
numerous, discrete RNAs from a single primary transcript
(Schwartz et al., 1990a, 1990b; Unger et al., 1991; Viglianti et
al., 1990). To determine whether p43 is translated from the full-
length SIVmac239 primary transcript or from a previously
unidentified RNA species potentially generated by RNA
splicing or a cryptic transcription start site, we first performed
Northern blot analysis on RNA isolated from SIVmac239-
transfected 293T cells (Fig. 3A). The [32P]-labeled antisense
RNA probe consisted of gag nucleotides 50–450, which
encompasses the initiation codon for p43 and extends into the
CA region. We reasoned that this probe would recognize all
transcripts encoding p43 since p43 contains the CA domain of
Pr55Gag. This probe detected only one band, corresponding to
the full-length SIV primary transcript, even after very long
exposures (data not shown), indicating that there are no
detectable alternative gag RNAs. However, since Northern
blots may lack the sensitivity to detect alternative RNAs if they
are present in very low quantities (Han and Zhang, 2002;
Kozak, 2001; Van Eden et al., 2004), we searched for alternative
gag RNAs by two additional methods which can detect much
lower levels of RNA: 5′ rapid amplification of cDNA ends (5′
RACE) and ribonuclease protection assay (RPA) (Dvorak et al.,
2003).
First, we performed 5′ RACE on RNA isolated from 293T
cells transfected with SIVmac239 proviral DNA using a reverse
primer that anneals approximately 200 bp downstream of the
p43 start codon AUG118. Along with the expected full-length
PCR product of 1144 bp, we consistently detected two smaller
products that, when sequenced, indicated that there are 5′
truncated (not spliced) gag transcripts initiating at nucleotide
196 and 299, herein referred to as gag196 and gag299, both of
which are located between AUG1 and AUG118 (data not
shown). If these transcripts were authentic, either could mediate
translation of p43 since AUG118 is the first start codon (in any
frame) from the 5′ end in both cases. Therefore, to confirm the
existence of gag196 and gag299, we performed a ribonuclease
protection assay on RNA isolated from SIVmac239-transfected
293T cells using the same probe used for Northern blot analysis
(Fig. 3B shows a diagram of the probe in relation to the
suspected alternate gag transcripts). [Note that in vitro
transcription of the probe adds 50 bases of vector sequence
that are not protected when hybridized to gag RNA. Therefore,
the undigested probe is 450 bases long.] If truncated gag196 and
gag299 transcripts are in fact produced, the protected probe
would yield bands at 254 and 151 bases, respectively, in
addition to the 400 base full-length target. Our results
demonstrate that, even with as much as 10 μg of RNA, this
Fig. 3. SIV p43 is not translated from alternative gag RNAs. (A) Total RNA from 293T cells transfected with GFP or SIVmac239 proviral DNA was subjected to
Northern blot analysis as described in Materials and methods. Arrow points to full-length primary transcript. Migration of a 0.24–9.5 kb RNA ladder (Invitrogen) is
shown on the left. (B). Schematic diagram of potential alternate gag transcripts (gag196 and gag299) in relation to full-length SIV gag RNA (top). The [32P]-labeled
probe used for ribonuclease protection assay is shown at the bottom. (C) RNase protection assay. The antisense RNA probe was hybridized with RNA isolated from
293T cells transfected with SIVmac239 proviral DNA and digested with RNase T1. Lane ‘P’ is undigested probe, lane ‘D’ is unhybridized, digested probe, and the
other lanes are probe hybridized with increasing amounts of RNA (1.25, 2.5, 5, 7.5, and 10 μg, respectively). The arrow with an asterisk at the right denotes full-length
probe (450 bases), and the arrow denotes full-length target (400 bases). Migration of an RNA Century Marker (Ambion) is shown on the left. (D) (Left) Full-length,
m7G-capped, poly(A)-tailed SIV gag RNAwas in vitro transcribed and resolved by electrophoresis as described in Materials and methods. Migration of a 0.24–9.5 kb
RNA ladder (Invitrogen) is shown at the left. (Right) gag RNA was translated in RRL and resolved by SDS-PAGE as described in Materials and methods.
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3C). Thus, we conclude that, if the transcripts identified by 5′
RACE are authentic, they are present in extremely low
quantities and are unlikely to account for the levels of p43
observed in our immunoprecipitation experiments.
To determine whether p43 can be translated from full-length
gag RNA, we first generated and purified in vitro transcribed
m7G-capped, poly(A)-tailed gag RNA (Fig. 3D, left). It is
important to note that a gag-alone vector was used as the
template for this and other in vitro transcription/translation
experiments presented below; the RNA transcribed from this
template does not include any of the SIV 5′ leader, which
harbors an IRES, but rather has a short leader of about 50 bases
of vector sequence. Our previous immunoprecipitation experi-
ments (Fig. 1B) demonstrated that p43 was expressed from a
gag-alone expression vector, indicating that translation of p43
was independent of the leader. When this gag mRNA was
translated in rabbit reticulocyte lysate (RRL), Pr55Gag and p43
were both synthesized (Fig. 3D). The observation that in vitro
translated, full-length gag RNA produces p43 provides
conclusive evidence that alternative gag RNAs are not required
for p43 expression.
Translation of SIV p43 does not occur via leaky ribosome
scanning
We next investigated the possibility that translation of p43
results from leaky ribosome scanning, in which some scanning40S ribosomal subunits bypass AUG1 (Pr55
Gag) and continue to
scan until translation is initiated at AUG118 (Kozak, 1989).
Selection of initiation codons has been shown to be highly
sequence-dependent, with an optimal context of CC[A/G]
CCAUGG; the most important nucleotides of this sequence are
the purine at −3 and guanosine at +4 (Kozak, 1986). While
AUG1 of SIVmac239 is present within a strong context
(GGGAGAUGG), we considered the possibility that structural
elements within gag RNA or other factors could affect initiation
at AUG1. In fact, one observation presented above suggested
that leaky scanning may be a feasible mechanism leading to
expression of p43: when AUG1 was mutated to AUC,
expression of p43 was dramatically increased (Fig. 1B). A
simple explanation for this observation is that the increase in
p43 reflects a decrease in competition for translation machinery.
However, another interpretation is that, in the absence of AUG1,
scanning 40S ribosomal subunits were free to scan until they
initiated translation at AUG118. To test the leaky scanning
hypothesis, we generated two additional mutants in the context
of the gag-alone expression vector, L(50)MKoz and I(85)MKoz,
which introduce new in-frame AUG codons between the start
codons for Pr55Gag and p43 at the amino acid positions
indicated. We also mutated the nucleotides surrounding both
new AUGs, placing them in the consensus sequence (CCAC-
CAUGG) for translation initiation. Additionally, we mutated
nucleotides surrounding AUG30, the only existing in-frame
AUG between AUG1 and AUG118, placing AUG30 in the
optimal context for initiation [mutant M(30)Koz]. If some 40S
Fig. 4. Translation of p43 does not occur via leaky scanning. Lysates prepared
from COS-1 cells that were transfected with GFP, SIV Pr55Gag pCI, M(30)Koz,
L(50)MKoz, or I(85)MKoz were labeled and immunoprecipitated as in Fig. 1A.
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scanning, they should in theory initiate translation at these
introduced start codons resulting in elimination of p43. We
immunoprecipitated Pr55Gag and p43 from [35S]-labeled lysates
of COS-1 cells transfected with either M(30)Koz, L(50)MKoz or I
(85)MKoz and found that the p43 expression was not eliminated
(Fig. 4). These data demonstrate that leaky scanning is not
responsible for translation of p43.
Translation of p43 is cap-independent
Having eliminated other reasonable mechanisms that could
mediate translation of p43, we next directly tested whether
translation of p43 was mediated by an IRES. Our first
approach was to determine whether translation of p43 was
dependent on the 5′ m7G cap on gag mRNA. We in vitro
transcribed gag RNAs that were capped with either m7GpppG
or ApppG, which is not recognized by the cap-binding
complex but has been shown to stabilize RNA in the absence
of the m7G cap (Byrd et al., 2005), and translated these RNAs
in RRL (Fig. 5A). As noted above, the gag-alone template
used for in vitro transcription does not include the SIV 5′
leader, so translation of Pr55Gag from these RNAs is predicted
to be cap-dependent. Although translation in RRL is not
strictly cap-dependent (Michel et al., 2000), we observed that
Pr55Gag was translated approximately 50% less from ApppG-Fig. 5. Translation of p43 is cap-independent. (A) SIV gag mRNAs were in vitro tra
RRL in the presence of [35S]Met/Cys. Translation products were resolved by SDS-PA
quantitated by band densitometry of gels from at least three independent translation r
was normalized to their respective levels from m7GpppG-capped RNA (gray bars).capped gag RNA than m7G-capped RNA; thus, our system
reflected cap dependence sufficiently to assess any cap
requirement of p43 (Fig. 5B). In stark contrast to Pr55Gag,
translation of p43 from ApppG-capped gag RNA was greatly
increased, clearly demonstrating that p43 translation occurs via
a cap-independent pathway (Fig. 5B).
Translation of p43 is stimulated when cap-dependent
translation is inhibited
To further investigate the cap independence of p43
translation, we examined the effect of excess endogenous
m7GpppG in RRL. Excess, free m7GpppG inhibits cap-
dependent translation by competitive binding of initiation
factor eIF4E (Cai et al., 1999) and has been shown to inhibit
cap-dependent translation in RRL (Rogers et al., 2004). We
in vitro translated m7G-capped gag RNAs in the presence of
0.1 mM and 0.25 mM free m7GpppG and, as a control,
0.25 mM free ApppG which should not affect cap-dependent
translation (Fig. 6A). Pr55Gag translation was unaffected in
the presence of 0.25 mM ApppG but was inhibited in the
presence of excess m7GpppG (Fig. 6B). However, while
excess ApppG had no effect on p43 translation, we
observed a dose-dependent increase in p43 translation with
the addition of excess m7GpppG, confirming that translation
of p43 occurs via a cap-independent mechanism and is, in
fact, stimulated by inhibition of the cap-dependent pathway
(Fig. 6B).
RRLs have been criticized for inefficient selection of the
appropriate start codon and have been shown, in some
circumstances, to bypass the first start codon and initiate at
the next AUG (Kozak, 1990). In gag RNA, there is one in-frame
AUG (AUG30) between AUG1 and AUG118 that could result in
translation of a protein with a predicted molecular weight of
54 kDa. In our in vitro translations, there is a faint band that
migrates just below Pr55Gag that may be the result of initiation
at AUG30. However, because the 54 kDa protein is translated at
such low levels, it is highly unlikely that p43 is translated as a
result of low fidelity initiation at AUG1. Thus, the results of our
RRL experiments strongly support the existence of an IRESnscribed with either m7GpppG or ApppG caps, poly(A)-tailed, and translated in
GE and visualized by phosphorimager analysis. (B) Pr55Gag and p43 levels were
eactions. Expression of Pr55Gag and p43 from ApppG-capped RNA (black bars)
Fig. 7. Replication kinetics of SIVmac239 p43(−). Cell-free supernatants of
CEM×174 cells transfected with wild-type (WT) SIVmac239 or SIVmac239
p43(−) were analyzed on the indicated days post-transfection using a standard
reverse transcriptase (RT) assay. The values plotted represent the RT activity of
SIVmac239 p43(−) normalized to WT SIVmac239 RT activity at each time
point from three independent experiments. Inset. Lysates prepared from COS-1
cells that were transfected with either WT SIVmac239 or SIVmac239 p43(−)
DNA were labeled with [35S]Met/Cys and immunoprecipitated as in Fig. 1A.
Note the absence of p43 in SIVmac239 p43(−).
Fig. 6. Translation of p43 is stimulated when cap-dependent translation in
inhibited. (A) In vitro transcribed m7GpppG-capped poly(A)-tailed gag RNAs
were translated in RRL in the presence of buffer (none), 0.25 mM ApppG (A) or
0.1 mM or 0.25 mM m7GpppG (m7G and black triangle). (B) Pr55Gag and p43
levels were measured by band densitometry of gels from at least three
independent translation reactions. Pr55Gag (gray bars) and p43 (black bars)
levels in the presence of ApppG or m7GpppG were normalized to their
respective levels in the presence of no excess cap (none).
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p43.
Replication kinetics of SIVmac239 p43(−)
Having determined the mechanism by which SIV p43 is
translated, we next investigated whether SIV p43 was involved
in virus replication. To this end, we mutated AUG118 to AUC
within SIVmac239, generating a full-length viral clone that did
not express p43, SIVmac239 p43(−) (Fig. 7, inset). CEM×174
cells were transfected with equal amounts of proviral DNA for
wild-type (WT) SIVmac239 and SIVmac239 p43(−), and virus-
containing cell supernatants were assayed for reverse transcrip-
tase (RT) activity at various time points following transfection
(Fig. 7). By day 6 post-transfection, SIVmac239 p43(−)
replication was enhanced 2-fold compared to WT SIVmac239
and remained approximately 2-fold higher throughout the time
course. The increase in replication kinetics observed for
SIVmac239 p43(−) suggests that SIV p43 negatively regulates
SIV replication in cell culture.
Discussion
In this study, we identify a previously undescribed SIV
Pr55Gag isoform, SIV p43. We demonstrate that SIV p43 is not
the result of proteolytic cleavage or degradation of Pr55Gag and
is translated independently of Pr55Gag from the primary gag
transcript. Our in vitro transcription and translation experiments
establish that translation of p43 occurs via a differentmechanism than that of Pr55Gag. Translation of p43 from gag
mRNA in vitro is cap-independent and is stimulated when cap-
dependent translation is inhibited. Thus, we conclude that
translation of p43 is mediated by an IRES within gag RNA.
Recently, reports of IRESs have been criticized for not
thoroughly examining all possible forms of RNA (Kozak, 2001,
2005). We carefully considered these criticisms when designing
the experiments presented in this paper and rigorously
examined the possibility that alternative gag RNAs could
encode p43. Dicistronic vector assays routinely used to identify
and map IRESs have also been criticized (Kozak, 2001, 2003).
In the studies presented herein, we were able to avoid the
potential pitfalls of using dicistronic assays to determine IRES
activity; by virtue of the independent translation of Pr55Gag and
p43, the coding regions of Pr55Gag and p43 are essentially
overlapping in-frame cistrons. Thus, rather than insert frag-
ments of gag into the intercistronic region of a standard
dicistronic vector to test its ability to drive a downstream
reporter, we were able to ask basic questions regarding
translation of p43 in its natural context: gag mRNA. Our in
vitro transcription and translation experiments clearly show
that, in the context of gag mRNA, p43 is translated efficiently
from uncapped RNA and when cap-dependent translation is
inhibited. The response of p43 expression under these
conditions was in stark contrast to Pr55Gag, which was
translated poorly from ApppG-capped leaderless gag RNAs
and during inhibition of cap-dependent translation.
It has long been clear that HIVand SIV have evolved several
intricate mechanisms to control gene expression, including Tat
activation of the 5′ LTR (Berkhout et al., 1989), the frameshift
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viral enzymes (Jacks et al., 1988), and Rev-dependent
expression of structural proteins (for a review, see Pollard and
Malim, 1998). More recently, HIV-1 and SIV have been shown
to harbor IRESs in their respective 5′ leaders (Brasey et al.,
2003; Ohlmann et al., 2000) and, with this report, within the
coding region of gag RNAs as well (Buck et al., 2001). The
presence of multiple IRESs represents another strategy
employed by HIV and SIV to regulate and maintain viral gene
expression.
The location of the HIV-1, HIV-2, and SIV gag IRESs is
intriguing and seems to contradict a basic concept of IRES-
mediated translation, namely that IRESs are described as highly
structured regions that are predicted to act as barriers to scanning
ribosomes (for review, see Hellen and Sarnow, 2001). Under this
concept, we might expect the HIVand SIV gag IRESs to inhibit
translation of Pr55Gag/Pr57Gag, the primary proteins translated
from gag, by hindering the progression of translating ribosomes.
Conversely, ribosomes actively translating Pr55Gag may occlude
ribosomes attempting entry at the IRES. In fact, our data suggest
that the latter possibility is occurring; when mutations were
introduced into our gag-alone expression vector that eliminated
expression of Pr55Gag (FSMA and M(1)IMA, Fig. 1B), p43
expression was dramatically increased. Thus, a stable structure
within the coding region of gag RNA may result in suboptimal
expression of both the precursor polyprotein and the IRES-
driven isoforms. However, maximal expression of viral genes is
hardly a goal of retroviruses; for example, it has long been
known that RNA sequences within gag and pol act as inhibitory
sequences that, in the absence of Rev, repress expression of
Pr55Gag and Pr160Gag-Pol (Cochrane et al., 1991; Schwartz et al.,
1992a, 1992b). Thus, regulation of SIV p43 expression may
very well be accomplished by placing p43 under control of an
IRES that, by virtue of its location, is not very efficient at
recruiting ribosomal subunits.
Several IRESs, including the HIV-1 leader IRES, p58PITSLRE,
hepatitis C virus, and ornithine decarboxylase, have been
shown to be highly active during the G2/M phase of the cell
cycle, a phase in which cap-dependent translation is repressed
(Brasey et al., 2003; Cornelis et al., 2000; Honda et al., 2000;
Pyronnet et al., 2000). In the case of the HIV-1 leader IRES,
this feature in conjunction with the Vpr-promoted enhance-
ment of HIV-1 transcription may help explain elevated virus
replication observed during G2/M-arrested cells (Brasey et al.,
2003; Goh et al., 1998). It is not known whether the gag
IRESs are regulated by the cell cycle nor is it known by what
mechanism either HIV-1 p40 or SIV p43 impacts virus
replication. Our observation that SIVmac239 p43(−) repli-
cates more efficiently than wild-type SIVmac239 suggests
that p43 negatively affects viral replication in cell culture. In
contrast, the HIV-1 IRES-driven isoform, p40, appears to be
required for viral replication, as an HIV-1 p40(−) virus
exhibits impaired replication kinetics in cell culture (Buck et
al., 2001). Future work should focus on the discovery of HIV-
1 p40 and SIV p43 function(s) in the viral lifecycle and
explore the possibility of cell cycle regulation of the gag
IRESs.Materials and methods
DNA constructs
The SIVmac239 D(25)APR mutant has been previously
described (Rue et al., 2003, 2005). SIVmac239 p43(−) was
generated by in vitro mutagenesis of SIVmac239 pBS− using
the QuikChange XL mutagenesis kit (Stratagene) with muta-
genesis primers (MWG Biotech) that encoded an ATG→ ATC
mutation at ATG118 of the MA domain of gag. SIV Pr55
GagpCI
was constructed by digesting vector HIV-1 Pr55Gag pCI-PRE
(Buck et al., 2001) (kindly provided by Robert Siliciano, Johns
Hopkins University, Baltimore, MD) with EcoR1 and Nhe1 to
remove HIV-1 Pr55Gag and replacing it with SIV gag PCR-
amplified from SIVmac239 pBS− with added EcoR1 and Nhe1
sites (5′ and 3′, respectively). Vectors FSMA, M(1)IMA, M
(30)MA, M(118)IMA, M(189)MA, M(30)koz, L(50)Mkoz, and I
(85)Mkoz were constructed by in vitro mutagenesis of the plas-
mid SIV Pr55GagpCI with the QuikChange mutagenesis kit
(Stratagene). Site-directed mutagenesis primers (MWG Bio-
tech) were designed according to recommendations of the
QuikChange manufacturer. FSMA contains a −1 frameshift at
base 53 of the MA domain of SIV gag. M(1)IMA, M(30)MA,
M(118)IMA, and M(189)MA all contain ATG→ ATC mutations
(mutated bases underlined) resulting in a Met → Ile sub-
stitution at the amino acid positions indicated. M(30)koz
contains the mutations AGTACATGT → CCACCATGG
which places AUG118 in optimal Kozak consensus sequence
(mutated bases underlined). L(50)Mkoz and I(85)Mkoz con-
tain the mutations AAAGCCTGT → CCACCATGG and
GCGTCATCT → CCACCATGG, respectively, resulting in
Leu → Met and Ile → Met substitutions with the cor-
responding AUG start codons in optimal Kozak sequences.
Vector SIV Pr55GagpGEM7Z was generated by PCR-amplify-
ing SIV gag from SIVmac239 with added BamH1 restriction
sites and inserting the digested fragment into pGEM-7Zf(+)
(Promega) at the same site. The plasmid Gag50–450pGEM4Z
was generated by PCR-amplifying gag nucleotides 50–450
from pSIV Pr55GagpCI with added EcoR1 and BamH1 sites
(5′ and 3′, respectively) and inserting the digested fragment
into pGEM-4Z (Promega) at the same restriction sites. This
placed the antisense strand under control of the T7 promoter.
All constructs described above were verified by sequencing.
Cell culture
African green monkey kidney COS-1 cells and human
embryonic kidney 293T cells (American Type Culture Collec-
tion, Manassas, Virginia) were maintained as previously
described (Rue et al., 2003).
Metabolic labeling
COS-1 cells at ∼40% confluence were transfected in T-75
flasks with 9.75 μg DNA using Lipofectamine Plus (Invitro-
gen) according to the manufacturer's instructions. One day
post-transfection, cells were labeled with [35S]Met/Cys as
332 M.G. Nicholson et al. / Virology 349 (2006) 325–334previously described (Rue et al., 2005), except that ∼0.11 mCi/
mL of Tran[35S]-Label ([35S]Met/Cys; ICN Pharmaceuticals)
was added for 4 h at 37 °C. Radiolabeled cells were washed in
phosphate-buffered saline (PBS), lysed in modified radio-
immunoprecipitation assay (RIPA) buffer (PBS with 1% [vol./
vol.] Igepal [NP-40], 0.5% [wt./vol.] sodium deoxycholate,
0.1% [wt./vol.] sodium dodecyl sulfate [SDS], 1 mM sodium
orthovanadate, and protease inhibitor cocktail III [Calbio-
chem]), and clarified by sonication and centrifugation. Cell
supernatants were filtered through a Millex 0.45-μm-pore-size
syringe-tip filter (Millipore), and radiolabeled virus was pelleted
through a 20% sucrose cushion in TNE buffer (20 mM Tris [pH
8.0], 150mMNaCl, and 2 mMEDTA) at 133,000 × g for 2 h at 4
°C. Virus pellets were then lysed in RIPA buffer.
For immunoprecipitation reactions, radiolabeled cell (500 μg)
and virus lysates were incubated with 3 μg of immunoglobulin
G (IgG)-purified rabbit SIV CA polyclonal antiserum (HRP) for
at least 1 h at 4 °C followed by an overnight incubation with
Protein A–agarose beads (Sigma-Aldrich) at 4 °C. Protein A–
agarose beads were pelleted and washed with RIPA buffer, after
which proteins were resolved by SDS-PAGE using either 10%
or 12.5% Tris–HCl Criterion pre-cast gels (Bio-Rad). Fixed
gels were analyzed using a Typhoon 9210 phosphorimager and
Molecular Dynamics ImageQuant version 5.5 software (Amer-
sham Pharmacia).
Northern blot analysis
Total cellular RNA was isolated from transfected 293T cells
using RNA STAT-60 kit (Tel-Test), treated with DNase and
purified with the RNeasy kit (Qiagen). Northern blot analysis
was performed with 10 μg of RNA using the NorthernMax Gly
kit (Ambion) according to the manufacturer's instructions.
Blots were probed with a [32P]UTP-labeled antisense RNA
probe generated by in vitro transcription of EcoR1-linearized
vector Gag50–450pGEM4Z with the MEGAScript T7 kit
(Ambion) in the presence of 3.125 μM [32P]UTP according to
the manufacturer's instructions. Blots were analyzed with a
Typhoon 9210 phosphorimager and Molecular Dynamics
ImageQuant version 5.5 software (Amersham Pharmacia).
5′ Rapid amplification of cDNA ends (RACE)
5′ RACE was performed using the FirstChoice RLM-RACE
kit from Ambion according to the manufacturer's recommenda-
tions on total RNA isolated as described above from 293T cells
transfected with SIVmac239 proviral DNA. The 3′ gene
specific primers used for nested PCR were as follows: 5′-
acggctccctaagttgtccttgt-3′ (outer) and 5′-gagaggaattctataa-
tatctctgataatctgc-3′ (inner). Taq-amplified PCR products were
cloned into pCR2.1 (Invitrogen) and sequenced using a
standard M13 Reverse primer.
RNase protection assay
Total cellular RNA was isolated from 293T cells transfected
with SIVmac239 proviral DNA as described above. RNA wassubjected to a ribonuclease protection assay using the RPA III
kit (Ambion) according to the manufacturer's recommenda-
tions. The probe used was identical to the probe used in
Northern blot analysis (described above). Protected RNA
probes were resolved by electrophoresis with 5% polyacryl-
amide/8 M Urea Criterion pre-cast gels (Bio-Rad).
In vitro transcription and translation
SIV Pr55GagpGEM7Z DNA was linearized with Mlu1 to
create templates for in vitro transcription. Capped run-off RNA
transcripts were generated using the MEGAScript T7 kit
(Ambion) including m7GpppG (Promega) or ApppG cap
analog (New England Biolabs) in the reaction according to
the manufacturer's recommendations. Poly(A) tails were added
to the in vitro transcribed RNAwith the Poly(A) Tailing kit from
Ambion. Capped poly(A)-tailed RNA transcripts were extracted
with phenol/chloroform and precipitated with 0.3 M sodium
acetate (pH 5.2) and 3 volumes of 100% ethanol. Unincorpo-
rated nucleotides were removed over a NucAway spin column
(Ambion). RNA concentrations were determined spectropho-
tometrically, and RNA integrity was monitored by electropho-
resis through a 16% formaldehyde denaturing 1.3% agarose gel.
Capped poly(A) tailed RNAs were translated in nuclease-
treated rabbit reticulocyte lysates (RRL) (Promega) in the
presence of [35S]Met/Cys according to the manufacturer's
recommendations. Following in vitro translation, proteins were
resolved by SDS-PAGE using 10% Tris–HCl Criterion pre-cast
gels (Bio-Rad) and analyzed as described above.
Virus replication
CEM×174 cells (5 × 106) were transfected with 12 μg of
proviral DNA by electroporation at 200 V and 960 μF using a
gene pulser (Bio-Rad). Virus replication was assessed by
performing standard reverse transcriptase (RT) assays (Cla-
bough et al., 1991) on cell-free supernatants from transfected
cells at various times post-transfection.
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